JREG:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF - USD (acc) (EUR)

ETF | Others |

Last Closing

USD 43.66

Change

+0.14 (+0.32)%

Market Cap

USD 0.23B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.14 (-0.28%)

USD 473.61B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.14%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.04 (+0.13%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.01 (-0.02%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.12 (+0.50%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-8.00 (-4.78%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.05 (+0.11%)

USD 101.50B
8R80:XETRA Amundi Index Solutions - Amund..

+0.30 (+0.21%)

USD 99.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.07 (+0.13%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.88 (+0.55%)

USD 80.38B

ETFs Containing JREG:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.14% 82% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.14% 82% B 80% B-
Trailing 12 Months  
Capital Gain 25.05% 82% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.05% 82% B 81% B-
Trailing 5 Years  
Capital Gain 93.23% 94% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 93.23% 94% A 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 19.93% 94% A 91% A-
Dividend Return 19.93% 94% A 90% A-
Total Return N/A 52% F 74% C
Risk Return Profile  
Volatility (Standard Deviation) 240.13% 2% F 2% F
Risk Adjusted Return 8.30% 35% F 35% F
Market Capitalization 0.23B 51% F 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.